Loading...
Back to narrative

ECH: Rising Discount Rate Will Likely Weigh on Near-Term Outlook

Update shared on 12 Nov 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
1.2%
7D
4.3%

Analysts have marginally increased their price target for Echo Investment from PLN 5.19 to PLN 5.19. This reflects only minimal adjustments to key forecast assumptions and maintains a steady outlook for the company.

Valuation Changes

  • Consensus Analyst Price Target remains unchanged at PLN 5.19.
  • The discount rate has risen slightly from 15.56% to 15.79%.
  • The revenue growth projection remains essentially the same at approximately 31.67%.
  • Net profit margin is unchanged, holding steady at around 17.39%.
  • The future P/E ratio has increased marginally from 7.55x to 7.60x.

Have other thoughts on Echo Investment?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.